295 related articles for article (PubMed ID: 22695045)
1. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study.
Dalal S; Hui D; Bidaut L; Lem K; Del Fabbro E; Crane C; Reyes-Gibby CC; Bedi D; Bruera E
J Pain Symptom Manage; 2012 Aug; 44(2):181-91. PubMed ID: 22695045
[TBL] [Abstract][Full Text] [Related]
2. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
[TBL] [Abstract][Full Text] [Related]
3. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia.
Di Sebastiano KM; Yang L; Zbuk K; Wong RK; Chow T; Koff D; Moran GR; Mourtzakis M
Br J Nutr; 2013 Jan; 109(2):302-12. PubMed ID: 23021109
[TBL] [Abstract][Full Text] [Related]
4. Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy.
Cloyd JM; Nogueras-González GM; Prakash LR; Petzel MQB; Parker NH; Ngo-Huang AT; Fogelman D; Denbo JW; Garg N; Kim MP; Lee JE; Tzeng CD; Fleming JB; Katz MHG
J Gastrointest Surg; 2018 Apr; 22(4):703-712. PubMed ID: 29230694
[TBL] [Abstract][Full Text] [Related]
5. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
6. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
7. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
8. Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer.
Sandini M; Patino M; Ferrone CR; Alvarez-Pérez CA; Honselmann KC; Paiella S; Catania M; Riva L; Tedesco G; Casolino R; Auriemma A; Salandini MC; Carrara G; Cristel G; Damascelli A; Ippolito D; D'Onofrio M; Lillemoe KD; Bassi C; Braga M; Gianotti L; Sahani D; Fernández-Del Castillo C
JAMA Surg; 2018 Sep; 153(9):809-815. PubMed ID: 29801062
[TBL] [Abstract][Full Text] [Related]
9. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
[TBL] [Abstract][Full Text] [Related]
10. Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer.
Daly LE; Ní Bhuachalla ÉB; Power DG; Cushen SJ; James K; Ryan AM
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):315-325. PubMed ID: 29318756
[TBL] [Abstract][Full Text] [Related]
11. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
12. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
13. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients.
Basile D; Parnofiello A; Vitale MG; Cortiula F; Gerratana L; Fanotto V; Lisanti C; Pelizzari G; Ongaro E; Bartoletti M; Garattini SK; Andreotti VJ; Bacco A; Iacono D; Bonotto M; Casagrande M; Ermacora P; Puglisi F; Pella N; Fasola G; Aprile G; Cardellino GG
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):368-377. PubMed ID: 30719874
[TBL] [Abstract][Full Text] [Related]
14. Marked loss of adipose tissue during neoadjuvant therapy as a predictor for poor prognosis in patients with gastric cancer: A retrospective cohort study.
Zhang Y; Li Z; Jiang L; Xue Z; Ma Z; Kang W; Ye X; Liu Y; Jin Z; Yu J
J Hum Nutr Diet; 2021 Jun; 34(3):585-594. PubMed ID: 33491826
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
[No Abstract] [Full Text] [Related]
16. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
17. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
Martin L; Birdsell L; Macdonald N; Reiman T; Clandinin MT; McCargar LJ; Murphy R; Ghosh S; Sawyer MB; Baracos VE
J Clin Oncol; 2013 Apr; 31(12):1539-47. PubMed ID: 23530101
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of abdominal body compositions on survival in advanced pancreatic cancer.
Bian X; Dai H; Feng J; Ji H; Fang Y; Jiang N; Li W
Medicine (Baltimore); 2018 Jun; 97(22):e10988. PubMed ID: 29851855
[TBL] [Abstract][Full Text] [Related]
20. Effect of adipose tissue volume on prognosis in patients with non-small cell lung cancer.
Lee JW; Lee HS; Na JO; Lee SM
Clin Imaging; 2018; 50():308-313. PubMed ID: 29751203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
